EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting

Gerrit Burger iD, Rafiou Adamou, Ruth Kreuzmair, Wilfrid Ndzebe Ndoumba, Dorothea Ekoka Mbassi, Anne Marie Nkoma Mouima, Carole Mamgno Tabopda, Roukoyath Moyoriola Adegnika, Ayong More, Dearie Glory Okwu, Lia-Betty Dimessa Mbadinga, Carlos Lamsfus Calle und 8 weitere

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Gerrit Burger und 19 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon. Hauptthemen laut MEDLINE: Loiasis, Eosinophils, Basophils, Loa. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation (DFG), Federal Ministry of Science, Research and Economy of Austria, Developing Countries Clinical Trials Partnership 2 programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Chronic infection by Loa loa remains an unsolved immunological paradox. Despite harboring subcutaneously migrating adult worms and often high densities of microfilariae, most patients experience only relatively mild symptoms, yet microfilaricidal treatment can trigger life-threatening inflammation. Here, we investigated innate cell populations hypothesized to play a role in these two faces of the disease, in an endemic population in Gabon. Methodology/Principal findings We analyzed numbers and activation of eosinophils and basophils, as well as myeloid-derived suppressor cell (MDSC) subsets and associated circulating cytokine levels by flow cytometry in sex- and age-matched L . loa -uninfected (LL-), -amicrofilaraemic (MF-) and -microfilaraemic (MF+) individuals (n = 42), as well as microfilaraemic individuals treated with albendazole (n = 26). The percentage of eosinophils was lower in LL- (3.0%) than in the combined L . loa -infected population, but was similar in MF+ (13.1%) and MF- (12.3%). Upon treatment of MF+, eosinophilia increased from day 0 (17.2%) to day 14 (24.8%) and had decreased below baseline at day 168 (6.3%). Expression of the eosinophil activation marker CD123 followed the same pattern as the percentage of eosinophils, while the inverse was observed for CD193 and to some extent CD125. Circulating IL-5 levels after treatment followed the same pattern as eosinophil dynamics. Basophil numbers did not differ between infection states but increased after treatment of MF+. We did not observe differences in MDSC numbers between infection states or upon treatment. Conclusions/Significance We demonstrate that both chronic infection and treatment of L . loa microfilaraemia are associated with eosinophil circulation and distinct phenotypical activation markers that might contribute to inflammatory pathways in this setting. In this first ever investigation into MDSC in L . loa infection, we found no evidence for their increased presence in chronic loiasis, suggesting that immunomodulation by L . loa is induced through other pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LoiasisEosinophilsBasophilsLoaMyeloid-Derived Suppressor CellsHumansMaleFemaleAdultGabonAnimalsMiddle AgedYoung AdultAlbendazoleChronic DiseaseFlow CytometryCytokinesEndemic DiseasesAdolescent

Substanzen

AlbendazoleCytokines

Autor:innen und Institutionen

  • Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
  • Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
  • Department of Implementation Research, Bernhard Nocht Institute for Tropical Medicine & I Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • German Center for Infection Research, Partner sites Hamburg-Borstel-Lübeck-Riems, Germany.
  • Centre for Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Gerrit Burger

Förderung

  • German Research Foundation (DFG)
  • Federal Ministry of Science, Research and Economy of Austria
  • Developing Countries Clinical Trials Partnership 2 programme
  • Open Access Publishing Fund of the University of Tübingen
  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Wissenschaft, Forschung und Wirtschaft

Zitieren

APA

Burger, G., Adamou, R., Kreuzmair, R., Ndoumba, W. N., Mbassi, D. E., Mouima, A. M. N., Tabopda, C. M., Adegnika, R. M., More, A., Okwu, D. G., Mbadinga, L. D., Calle, C. L., Veletzky, L., Metzger, W. G., Mordmüller, B., Ramharter, M., Mombo-Ngoma, G., Adegnika, A. A., Zoleko-Manego, R., & McCall, M. B. B. (2024). Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012203

Vancouver

Burger G, Adamou R, Kreuzmair R, Ndoumba WN, Mbassi DE, Mouima AMN, et al. Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012203

BibTeX
@article{Burger2024,
  author = {Burger, Gerrit and Adamou, Rafiou and Kreuzmair, Ruth and Ndoumba, Wilfrid Ndzebe and Mbassi, Dorothea Ekoka and Mouima, Anne Marie Nkoma and Tabopda, Carole Mamgno and Adegnika, Roukoyath Moyoriola and More, Ayong and Okwu, Dearie Glory and Mbadinga, Lia-Betty Dimessa and Calle, Carlos Lamsfus and Veletzky, Luzia and Metzger, Wolfram Gottfried and Mordmüller, Benjamin and Ramharter, Michael and Mombo-Ngoma, Ghyslain and Adegnika, Ayola Akim and Zoleko-Manego, Rella and McCall, Matthew B B},
  title = {Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012203}
}
Kostenlos starten →